Expert profile

Dr. Nicola Mason

Veterinary immunologist and cancer researcher

Comparative oncology • cancer immunotherapy • CAR T-cell + mRNA cancer therapies

1Discussion
46 minAnalysed
Last reviewed: Jun 7, 2026·Credential: VMD, PhD, Professor (Penn Vet)·First indexed: Jun 7, 2026

About the expert

Focus: Cutting-edge cancer immunotherapy research bridging veterinary and human medicine through the One Health framework

Professor at the University of Pennsylvania School of Veterinary Medicine. Leads the Cancer Moonshot Canine Immunotherapy Network, the NIH/NCI initiative using spontaneously occurring canine cancers as a translational model for human cancer immunotherapy. Her lab works on CAR T-cell therapies derived from healthy donors (off-the-shelf approaches) and mRNA technology that prompts the patient's own body to produce cancer-fighting antibodies. Mainstream-anchored research credentials at the highest tier of academic veterinary oncology.

Expert discussions with Dr. Nicola Mason

Dr. Nicola Mason's discussions are not available yet.

Dr. Nicola Mason — toClarity